Instability of the ecstasy market and a new kid on the block: mephedrone

Journal of Psychopharmacology - Tập 25 Số 11 - Trang 1543-1547 - 2011
Tibor M. Brunt1, Anneke Poortman2, Raymond Niesink1, Wim van den Brink3
1Drug Information and Monitoring System, Netherlands Institute of Mental Health and Addiction, Utrecht, The Netherlands
2Netherlands Forensic Institute, The Hague, The Netherlands
3Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Tóm tắt

Recently, several reports have indicated instability of the ecstasy market in the Netherlands and other EU countries. In the current study, we demonstrate this instability in the Netherlands, showing a decrease of ecstasy tablets containing 3,4-methylenedioxymetamphetamine (MDMA) by more than 50% in 2009. In addition, we describe a partial replacement of MDMA in tablets sold as ecstasy by a previously unseen substance, mephedrone (or 4-methylmethcathinone). Mephedrone was quantified and ecstasy tablets contained between 96 and 155 mg of this new compound. So far, no studies about mephedrone’s effects have been published. For this study, we gathered information on the acute subjective effects of mephedrone from 70 regular ecstasy users. Overall, the majority of users considered the effects enjoyable. Mephedrone seemed to evoke effects similar to other amphetamine type psychostimulants, including MDMA. In contrast to MDMA, however, mephedrone induced strong feelings of craving in most users. If the unstable ecstasy market situation persists, the potential of mephedrone to substitute for MDMA might be substantial. Mephedrone, sold as ecstasy, is therefore likely to be a valid cause for health concern.

Từ khóa


Tài liệu tham khảo

10.1111/j.1360-0443.2006.01423.x

BBC News (2009) Police warning over ‘bubble’ drug. Retrieved from: http://news.bbc.co.uk/2/hi/uk_news/england/tees/8370130.stm (accessed 22 June 2010).

10.1016/j.forsciint.2005.04.023

10.1177/0269881109102541

10.1080/13556210500350794

10.1080/02791072.1995.10472472

10.1046/j.1600-0773.2003.pto930504.x

10.1016/S0091-3057(97)00323-7

Dick D, 2010, Mix Mag, 225, 44

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2008) Annual Report 2008. Retrieved from: http://www.emcdda.europa.eu/attachements.cfm/att_64227_EN_EMCDDA_AR08_en.pdf (accessed 22 June 2010).

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2009) Annual Report 2009. Retrieved from: http://www.emcdda.europa.eu/attachements.cfm/att_93236_EN_EMCDDA_AR2009_EN.pdf (accessed 22 June 2010).

European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2010) EMCDDA and Europol step up information collection on mephedrone. Retrieved from: http://www.emcdda.europa.eu/publications/drugnet/online/2010/69/article3 (accessed 22 June 2010).

10.1001/jama.1993.03500190050033

Gygi MP, 1996, J Pharmacol Exp Ther, 276, 1066

10.1016/S0149-7634(98)00046-3

10.1177/0269881106060513

10.1016/0736-4679(90)90288-7

10.1523/JNEUROSCI.18-20-08417.1998

10.1097/00007691-200404000-00007

10.5042/daat.2010.0123

Newcombe R (2009) The use of Mephedrone (M-cat, Meow) in Middlesbrough. Retrieved from: http://www.lifeline.org.uk/docs/M-cat%20report%20small.pdf (accessed 22 June 2010).

10.1007/978-0-387-76678-2_19

10.1089/109493103322278790

10.1111/j.1600-0404.2007.00818.x

Sparago M, 1996, J Pharmacol Exp Ther, 279, 1043

10.1056/NEJMoa072488

10.1080/15563650802010388

10.1111/j.1360-0443.2009.02707.x

10.1016/j.drugpo.2008.03.007

Thông tin
Thông tin xuất bản

Journal of Psychopharmacology

Tập 25 Số 11

1543-1547

Thông tin tác giả